Atlas Trials

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Clinical trial NCT03959501 · COMPLETED

Trial details

NCT number
NCT03959501
Sponsor
The University of Hong Kong
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 DiabetesKetonemia
Start date
2017-08-16
Primary completion
2020-10-16
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.